M&T Bank’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-5,531
Closed -$219K – 1593
2021
Q4
$219K Buy
+5,531
New +$252K ﹤0.01% 1410
2021
Q3
– Sell
-4,480
Closed -$249K – 1587
2021
Q2
$249K Sell
4,480
-843
-16% -$44.9K ﹤0.01% 1353
2021
Q1
$249K Sell
5,323
-3,074
-37% -$149K ﹤0.01% 1319
2020
Q4
$366K Sell
8,397
-7,255
-46% -$268K ﹤0.01% 1227
2020
Q3
$573K Buy
15,652
+1,030
+7% +$35K ﹤0.01% 913
2020
Q2
$426K Buy
14,622
+3,747
+34% +$104K ﹤0.01% 1009
2020
Q1
$284K Buy
+10,875
New +$332K ﹤0.01% 1153

Other funds holding HCAT

M&T Bank's HCAT Position: Q1 2022 in Review

M&T Bank sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 5,531 shares — an estimated $219K sold.

M&T Bank first reported a position in HCAT in Q1 2020 and held it in 7 quarters. The position peaked at $573K in Q3 2020. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • M&T Bank reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • M&T Bank sold 5,531 Health Catalyst shares in Q1 2022, an estimated $219K.
  • M&T Bank first reported a position in Health Catalyst in Q1 2020 and held it in 7 quarters.
  • M&T Bank's Health Catalyst position peaked at $573K in Q3 2020.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on M&T Bank's 13F filing for Q1 2022, filed 9 May 2022.